Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Statements of Cash Flows

v3.5.0.2
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 01, 2016
Oct. 03, 2015
Cash Flows From Operating Activities:    
Net Income $ 38,539 $ 53,067
Adjustments to Reconcile Net Income to Cash Provided By Operating Activities:    
Depreciation and Amortization 19,457 18,831
Provisions for Non-Cash Losses on Inventory and Receivables 1,554 1,513
Stock Compensation Expense 1,876 1,740
Deferred Tax Benefit (3,527) (243)
Non-cash Earnout Liability Adjustment 0 (1,576)
Other 401 21
Cash Flows from Changes in Operating Assets and Liabilities:    
Accounts Receivable (23,707) (29,796)
Inventories (5,113) (4,805)
Accounts Payable 211 (1,656)
Accrued Expenses (786) 5,662
Other Current Assets and Liabilities (460) (498)
Customer Advanced Payments and Deferred Revenue (11,281) (5,396)
Income Taxes 6,860 5,072
Supplemental Retirement and Other Liabilities 1,126 1,238
Cash Provided By Operating Activities 25,150 43,174
Cash Flows From Investing Activities:    
Acquisition of Business, Net of Cash Acquired 0 (52,606)
Capital Expenditures (9,869) (15,857)
Other Investing Activities (1,585) (2,677)
Cash Used For Investing Activities (11,454) (71,140)
Cash Flows From Financing Activities:    
Proceeds from Long-term Debt 20,000 55,000
Payments for Long-term Debt (25,909) (29,008)
Purchase of Outstanding Shares for Treasury (17,446) 0
Debt Acquisition Costs (164) 0
Proceeds from Exercise of Stock Options 3,902 3,308
Acquisition Earnout Payments 0 (2)
Income Tax Benefit from Exercise of Stock Options 529 619
Cash (Used For) Provided By Financing Activities (19,088) 29,917
Effect of Exchange Rates on Cash 109 (715)
(Decrease) Increase in Cash and Cash Equivalents (5,283) 1,236
Cash and Cash Equivalents at Beginning of Period 18,561 21,197
Cash and Cash Equivalents at End of Period $ 13,278 $ 22,433